BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 19040280)

  • 1. Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes.
    Tabuchi A; Tanaka J; Katayama K; Mizui M; Matsukura H; Yugi H; Shimada T; Miyakawa Y; Yoshizawa H
    J Med Virol; 2008 Dec; 80(12):2064-8. PubMed ID: 19040280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus.
    Tsuge M; Hiraga N; Takaishi H; Noguchi C; Oga H; Imamura M; Takahashi S; Iwao E; Fujimoto Y; Ochi H; Chayama K; Tateno C; Yoshizato K
    Hepatology; 2005 Nov; 42(5):1046-54. PubMed ID: 16250045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
    Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
    Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of hepatitis B virus genomes and infectivity in human serum samples.
    Hsia CC; Purcell RH; Farshid M; Lachenbruch PA; Yu MY
    Transfusion; 2006 Oct; 46(10):1829-35. PubMed ID: 17002641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C.
    Komiya Y; Katayama K; Yugi H; Mizui M; Matsukura H; Tomoguri T; Miyakawa Y; Tabuchi A; Tanaka J; Yoshizawa H
    Transfusion; 2008 Feb; 48(2):286-94. PubMed ID: 18028278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents.
    Ilan E; Burakova T; Dagan S; Nussbaum O; Lubin I; Eren R; Ben-Moshe O; Arazi J; Berr S; Neville L; Yuen L; Mansour TS; Gillard J; Eid A; Jurim O; Shouval D; Reisner Y; Galun E
    Hepatology; 1999 Feb; 29(2):553-62. PubMed ID: 9918935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-species transmission of gibbon and orangutan hepatitis B virus to uPA/SCID mice with human hepatocytes.
    Sa-Nguanmoo P; Tanaka Y; Ratanakorn P; Sugiyama M; Murakami S; Payungporn S; Sommanustweechai A; Mizokami M; Poovorawan Y
    Virus Res; 2011 Jun; 158(1-2):209-15. PubMed ID: 21510984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice.
    Vanwolleghem T; Libbrecht L; Hansen BE; Desombere I; Roskams T; Meuleman P; Leroux-Roels G
    J Hepatol; 2010 Sep; 53(3):468-76. PubMed ID: 20591528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection.
    Matsubara N; Kusano O; Sugamata Y; Itoh T; Mizuii M; Tanaka J; Yoshizawa H
    Transfusion; 2009 Mar; 49(3):585-95. PubMed ID: 19192255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.
    Hsieh YH; Su IJ; Wang HC; Chang WW; Lei HY; Lai MD; Chang WT; Huang W
    Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection.
    Meuleman P; Steyaert S; Libbrecht L; Couvent S; Van Houtte F; Clinckspoor F; de Hemptinne B; Roskams T; Vanlandschoot P; Leroux-Roels G
    Clin Chim Acta; 2006 Apr; 366(1-2):156-62. PubMed ID: 16253217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
    Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K
    Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice.
    Tsuge M; Hiraga N; Akiyama R; Tanaka S; Matsushita M; Mitsui F; Abe H; Kitamura S; Hatakeyama T; Kimura T; Miki D; Mori N; Imamura M; Takahashi S; Hayes CN; Chayama K
    J Gen Virol; 2010 Jul; 91(Pt 7):1854-64. PubMed ID: 20219897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice.
    Komatsu H; Inui A; Murano T; Tsunoda T; Sogo T; Fujisawa T
    BMC Res Notes; 2015 Aug; 8():366. PubMed ID: 26289533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intrauterine HBV infection: risk factors and impact of HBV DNA].
    Yin YZ; Chen XW; Li XM; Hou HY; Shi ZJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1452-4. PubMed ID: 17062350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo.
    Galun E; Nahor O; Eid A; Jurim O; Rose-John S; Blum HE; Nussbaum O; Ilan E; Daudi N; Shouval D; Reisner Y; Dagan S
    Virology; 2000 May; 270(2):299-309. PubMed ID: 10792989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectivity studies of hepatitis A and B in non-human primates.
    Maynard JE; Krushak DH; Bradley DW; Berquist KR
    Dev Biol Stand; 1975; 30():229-35. PubMed ID: 173599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic mice as a chemotherapeutic model for hepatitis B virus infection.
    Morrey JD; Korba BE; Sidwell RW
    Antivir Ther; 1998; 3(Suppl 3):59-68. PubMed ID: 10726056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
    Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
    Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.